IR vs PRME · P/E 49, rev $3.90B vs rev $4.6M
Ingersoll Rand Inc (IR) versus Prime Medicine, Inc. Common Stock (PRME) — a side-by-side from cached financials, not a winner call.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
Latest reported IR revenue for 2026-06-30 was $3.90B. Net income was $448.9M. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Latest reported PRME revenue for 2025-12-31 was $4.6M. Net income was -$201.1M. Revenue was up 55.3% from 2024-12-31 to 2025-12-31. PRME currently screens at market cap $570.8M.
IR currently screens at market cap $28.27B and trailing P/E 48.8. PRME currently screens at market cap $570.8M.
Not investment advice. Open the IR and PRME stock pages for the full models.
Not investment advice.